PolyPhotonix is a biophotonic research and development company that designs, develops and manufactures non-invasive photonic based medical devices. Established in 2009 in the North East of England, the company is focused on light therapy treatments for macular eye disease and has successfully brought its first medical device through clinical trials to market. The Noctura 400 Sleep Mask is a transformational treatment for Diabetic Retinopathy and Diabetic Macular Oedema, which are serious complications of diabetes and are the principal causes of blindness among people of working age in the UK. For more details visit our product website www.noctura.com. Contact us on: +44 (0) 1740 625 555 Email: enquiries@polyphotonix.com Website: www.polyphotonix.com
| Website | http://www.polyphotonix.com |
| Revenue | $6 million |
| Employees | 13 (9 on RocketReach) |
| Founded | 2009 |
| Phone | +44 1740 669139 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Medical Devices, Business Services General, Medical Device, Business Services, Health Care |
| Web Rank | 31 Million |
| Keywords | Light Based Therapy, Light Therapy, Photonic Devices, Biophotonics, Non Invasive, Device Manufacturing, Research And Development, Medical Technology, Health Technology, Ophthalmic Devices, Eye Care, Sleep Apnea, Phototherapy, Optoelectronics, Photonics, Therapeutic Devices, Healthcare, Medical |
| Competitors | Roche, Novartis, Regeneron, Alcon, Bausch + Lomb, Amgen, Santen, EyePoint Pharmaceuticals, STAAR Surgical, Viela Bio +40 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular PolyPhotonix employee's phone or email?
The PolyPhotonix annual revenue was $6 million in 2026.
Richard Kirk is the CEO of PolyPhotonix.
9 people are employed at PolyPhotonix.
The NAICS codes for PolyPhotonix are [5417, 54, 541].
The SIC codes for PolyPhotonix are [873, 87].